Nevertheless, since irisin treatment was begun well after the pathogenic cascade was initiated by the α-syn PFF injection, there is considerable promise that it might be developed as a disease-modifying therapy for the treatment of PD. The gene discussed is FNDC5; the disease is Parkinson disease.